Success Story: An Indian Research Specialist Secures NIW Approval with Help from Our Expert Team
Client’s Testimonial:
“It is my pleasure to write about the Chen Immigration Law Firm. When I first started, I was completely unsure of what to do, so I sent my CV to Chen Immigration for evaluation. After reviewing my CV, they provided me with a detailed explanation of what I was eligible for and what steps I should take moving forward.
I carefully followed the step-by-step guidance they provided, and I am very happy that I chose such a talented and knowledgeable firm that truly knows what they are doing.
The most important part of my journey was that I had no prior knowledge about the application process, not even a single step, and I asked thousands of questions along the way. Despite this, they were always polite, patient, and incredibly prompt in answering all my queries.
I highly recommend the Chen Immigration Law Firm to anyone looking to file their USCIS applications. Their expertise and support made the entire process smooth and successful for me.”
On April 30th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Specialist in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Research Specialist
Country of Origin: India
State of Residence at the Time of Filing: Maryland
Approval Notice Date: April 30th, 2025
Processing Time: 1 year, 15 days
Case Summary:
We are pleased to share that our team successfully secured NIW (National Interest Waiver) approval for a talented research specialist in the field of cancer biology from India. His groundbreaking research focuses on Gene therapy and immunotherapy, advancing non-invasive monitoring tools for patient comfort, with the goal of improving treatment effectiveness while reducing patient discomfort.
Our client retained our services to file an I-140 NIW petition. After evaluating his profile, we identified key elements to highlight in the petition:
● 8 peer-reviewed journal articles, 1 preprint, and 1 conference abstract published in leading journals
● 63 citations, including multiple references from top researchers worldwide.
● 2 publications ranked among the top 10% most cited in Biology & Biochemistry.
● Completed 18 peer reviews for authoritative journals, underlining his expertise.
We detailed how his proposed endeavor contributes to a nationally important goal: improving cancer care in the U.S. His research addresses the growing need for less invasive and more precise cancer treatments, directly benefiting patient outcomes and public health.
In addition, we emphasized his current employment as a research specialist at a U.S. institution, where he continues to work on developing gene therapy and immunotherapy along with novel non-invasive monitoring methods. Two letters from experts in the field further supported his significance as a contributor to cutting-edge biomedical research.
Thanks to our tailored strategy and the client’s strong credentials, his NIW was approved in 1 year and 15 days, with no RFE. We congratulate him on this achievement and are proud to have supported his path toward making meaningful contributions in the U.S.